A detailed history of Alliancebernstein L.P. transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 20,621 shares of FLGT stock, worth $343,133. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,621
Previous 20,621 -0.0%
Holding current value
$343,133
Previous $404,000 10.64%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$19.09 - $22.57 $62,424 - $73,803
3,270 Added 18.85%
20,621 $404,000
Q1 2024

May 14, 2024

SELL
$21.55 - $29.29 $56,030 - $76,154
-2,600 Reduced 13.03%
17,351 $376,000
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $1,363 - $2,081
51 Added 0.26%
19,951 $533,000
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $153,445 - $189,365
-5,221 Reduced 20.78%
19,900 $621,000
Q4 2022

Feb 14, 2023

SELL
$29.23 - $40.28 $1,870 - $2,577
-64 Reduced 0.25%
25,121 $748,000
Q3 2022

Nov 15, 2022

BUY
$37.92 - $63.74 $4,019 - $6,756
106 Added 0.42%
25,185 $960,000
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $3,502 - $4,580
73 Added 0.29%
25,079 $1.37 Million
Q1 2022

May 13, 2022

BUY
$49.85 - $96.11 $6,530 - $12,590
131 Added 0.53%
25,006 $1.56 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $3,169 - $4,305
41 Added 0.17%
24,875 $2.5 Million
Q3 2021

Nov 10, 2021

SELL
$74.87 - $110.87 $494,890 - $732,850
-6,610 Reduced 21.02%
24,834 $2.23 Million
Q2 2021

Jul 30, 2021

BUY
$66.8 - $100.45 $621,908 - $935,189
9,310 Added 42.06%
31,444 $2.9 Million
Q1 2021

May 06, 2021

BUY
$59.3 - $183.85 $570,466 - $1.77 Million
9,620 Added 76.87%
22,134 $2.14 Million
Q3 2020

Nov 12, 2020

SELL
$15.89 - $50.51 $98,295 - $312,454
-6,186 Reduced 33.08%
12,514 $501,000
Q2 2020

Aug 13, 2020

BUY
$8.89 - $18.28 $166,243 - $341,836
18,700 New
18,700 $299,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $504M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.